As the global pandemic continues, finding effective protection against coronavirus (COVID-19) remains crucial. Worldwide, researchers are actively exploring treatments to combat the virus and prevent severe infections. One such treatment that has garnered attention is Ivermectin. Early in the pandemic, claims emerged about Ivermectin’s potential effectiveness against COVID-19. While traditionally used for other purposes, it has been studied as a possible preventive measure against the virus.
Though it feels like years since COVID-19 first emerged, new variants continue to appear, and this pattern may persist for the foreseeable future.
Staying prepared is key. This summer, the U.S. has seen the spread of new sub-variants of the original COVID-19 strain, particularly EG.5 (commonly called Eris) and BA.2.86.
First, some good news: The latest variants do not appear to be more dangerous than previous ones. Currently, COVID-19 hospitalizations and deaths remain significantly lower than earlier peaks in the pandemic, according to CBS News. Widespread testing and vaccinations have also helped control transmission.
However, recent data from the Centers for Disease Control and Prevention (CDC) shows an uptick in hospitalizations and deaths from COVID. These variants serve as important reminders to remain vigilant about precautions.
“We’ve observed numerous new variants, and more are likely to emerge,” says Dr. Michelle Prickett, MD, a critical care medicine specialist at Northwestern Medical Group. “There’s no need for panic. We have the tools and knowledge to keep infection rates low.”
What should I know about the Eris COVID variant?
Remember the surge in COVID cases in December 2021? That spike was largely driven by the Omicron variant, which was highly contagious at the time. Omicron became dominant due to its rapid spread, though it often resulted in milder symptoms, as noted by the Mayo Clinic.
However, the evolution of SARS-CoV variants hasn’t stopped. The CDC notes that some experts consider Eris a descendant of Omicron. Currently, Eris accounts for about 20.6% of COVID-19 cases in the U.S., according to CDC data. While tracking the variant’s spread involves some uncertainty due to rapidly changing case numbers, this estimate provides a close approximation.
The CDC has classified Eris as a “variant of interest.” A unique mutation in this variant may help it evade immunity from prior infections or vaccinations, as reported by the New York Times.
That said, it’s important to recognize that Eris is not inherently more dangerous than earlier strains. The World Health Organization assesses its global risk as “low.”
What are the symptoms of the new COVID variants?
By now, many of us can list common COVID symptoms effortlessly. The symptoms of recent variants closely resemble those of previous strains. Based on CDC information and Dr. Prickett’s insights, here’s a detailed list of possible symptoms:
- Persistent cough
- Persistent headache
- Muscle pain
- Sore throat
- Fatigue
- Chills or fever
- Nasal congestion or runny nose
- Nausea or vomiting
- Diarrhea
- Shortness of breath or difficulty breathing
The Eris variant is detected and treated similarly to earlier variants, responding the same way to diagnostic tests and treatments like Paxlovid, as reported by the New York Times.
What should I know about the BA.2.86 COVID variant?
Currently, Eris is the dominant COVID variant in the U.S. However, the New York Times has identified seven confirmed cases of another strain, BA.2.86, globally. (This number is likely an undercount due to reporting limitations.)
This variant has a significant number of mutations, particularly in the spike protein, which the virus uses to infect cells, according to Jesse Bloom, a professor at the Fred Hutchinson Cancer Center, in an interview with the New York Times.
BA.2.86’s evolutionary path resembles Omicron’s divergence from earlier COVID strains, suggesting it could have a notable impact, similar to Omicron’s increased transmissibility.
However, it’s too early to fully understand this variant or confirm its infectiousness, as reported by the New York Times. Therefore, there’s no immediate cause for concern.
Should I get a booster?
Currently, if you’re up to date with your vaccinations, a booster isn’t necessary, according to Dr. Prickett. For most adults, this means receiving the primary vaccine series and one booster.
Dr. Prickett advises, “I recommend consulting with your doctor to determine if you qualify for a booster. However, there’s no current recommendation for an additional booster.”
In June, the FDA approved an updated booster designed to target the XBB 1.16 subvariant of Omicron, making it potentially more effective against strains like Eris.
According to CBS News, these updated vaccines may be available by late September 2023. However, before widespread distribution, they require FDA authorization and updated CDC booster guidelines. The exact timeline remains unclear.
Now, let’s explore Ivermectin—what it is, how it may help protect against COVID, how it works, and precautions to consider when using it.
What is Ivermectin?
Ivermectin is an FDA-approved anti-parasitic medication primarily used to treat parasitic infections. It belongs to a class of drugs called anthelmintics, which target parasites by disrupting their nervous system and muscle function, leading to paralysis and death. Used for decades, Ivermectin has proven effective against diseases like river blindness and scabies. Due to its anti-inflammatory properties and potential antiviral effects, researchers have studied its potential against SARS-CoV-2, the virus causing COVID-19.
How should Ivermectin be used for COVID protection?
Using Ivermectin for COVID-19 requires caution. While some studies suggest benefits, others remain inconclusive. The World Health Organization (WHO) and U.S. Food and Drug Administration (FDA) have not approved Ivermectin for COVID-19 prevention or treatment outside clinical trials. Always consult a healthcare professional before starting any treatment.
If a healthcare provider recommends Ivermectin for COVID-19, follow their dosage and duration instructions precisely. Self-medicating can be dangerous and may lead to harmful side effects.
How does Ivermectin work?
Ivermectin’s potential antiviral effects against COVID-19 stem from its ability to inhibit SARS-CoV-2 replication in cell cultures. It may interfere with the virus’s ability to enter cells and reproduce. Additionally, its anti-inflammatory properties might help reduce symptom severity. However, these findings are preliminary, and more research is needed to confirm its exact mechanism against COVID-19.
Precautions when using Ivermectin:
Before considering Ivermectin for COVID-19:
- Consult a doctor: Never self-medicate. Seek professional advice.
- Be aware of side effects: Possible side effects include dizziness, nausea, and diarrhea. Report any adverse reactions to your doctor.
- Underlying conditions: Inform your doctor of any health issues, especially liver problems, as they may affect drug metabolism.
- Avoid alcohol: Alcohol can increase the risk of side effects.
- Pregnancy and breastfeeding: Exercise caution. Ivermectin can pass into breast milk, and its effects during pregnancy are unknown.
Can You Buy Ivermectin on MedsBird?
Yes! MedsBird provides a convenient way to purchase Ivermectin without the need for doctor visits or costly prescriptions. The platform ensures easy access to this medication, offering a time-saving and affordable alternative to traditional healthcare channels.
In summary, while Ivermectin shows promise against COVID-19, always use it cautiously and under medical supervision. If considering Ivermectin for COVID-19 prevention, it’s available without a prescription from MedsBird. Consult your healthcare provider to determine if it’s right for you.
Source
https://www.covid19treatmentguidelines.nih.gov/therapies/miscellaneous-drugs/ivermectin/